SCHEMBL4882670

SCHEMBL4882670

Fc1ccc(-n2nccc2C(F)(F)F)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.42
NTRK1 P04629 2/20 0.35
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
KAT2B Q92831 1/20 0.33
MLYCD O95822 1/20 0.32
AR P10275 1/20 0.32
TRPV1 Q8NER1 2/20 0.32
PTGS2 P35354 3/20 0.32
PTGS1 P23219 2/20 0.32
RXRA P19793 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2B Q13224 1/20 0.31
TRPC1 P48995 1/20 0.31
TRPC3 Q13507 1/20 0.31
STIM1 Q13586 1/20 0.31
ORAI1 Q96D31 1/20 0.31
POLB P06746 1/20 0.31
MAPK9 P45984 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4882306 0.80 KDM4E (0.48) KDM4EPTGS2PTGS1
SCHEMBL4854437 0.79 KDM4E (0.47) KDM4EPTGS2PTGS1ORAI1
SCHEMBL4886275 0.78 POLB (0.43) KDM4ENTRK1POLB
SCHEMBL4883251 0.77 HPGD (0.44) KDM4ENTRK1TRPV1
SCHEMBL24303668 0.75 KDM4E (0.47) KDM4ENTRK1PTGS2PTGS1POLB
SCHEMBL28260479 0.75 KDM4E (0.47) KDM4EPTGS2PTGS1TRPC3
SCHEMBL598084 0.75 KDM4E (0.50) KDM4ENTRK1PTGS2POLB
SCHEMBL4886599 0.75 KDM4E (0.47) KDM4EPTGS2PTGS1POLB
SCHEMBL4988967 0.74 KDM4E (0.56) KDM4ENTRK1PTGS1POLB
SCHEMBL13629598 0.72 PTGS2 (0.41) KDM4ENTRK1PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES ICAGEN, INC. (US) 2008-03-13 US disclosed
US-7223782-B2 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2007-05-29 US disclosed
US-20050049237-A1 Pyrazole-amides and -sulfonamides ICAGEN, INC. (US) 2005-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064690-A1 PYRAZOLE-AMIDES AND -SULFONAMIDES SCN3A, TRPV3, HCN3 KDM4E 2869/4885NTRK1 1325/4885KDM5A 2106/4885
US-20050049237-A1 Pyrazole-amides and -sulfonamides SCN3A, TRPV3, HCN3 KDM4E 2869/4885NTRK1 1325/4885KDM5A 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.